ME01333B - Kladribinski režim za liječenje multiple skleroze - Google Patents

Kladribinski režim za liječenje multiple skleroze

Info

Publication number: ME01333B
Authority: ME; Montenegro
Prior art keywords: multiple sclerosis; treatment; cladribin; mode; preparation
Prior art date: 2004-12-22

Application number

MEP-2012-35A

Other languages

English (en)

Unknown language (me)

Inventor

Luca Giampiero De

Arnaud Ythier

Alain Munafo

Maria Lopez-Bresnahan

Original Assignee

Merck Serono Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-22

Filing date

2005-12-20

Publication date

2013-12-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34930135&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME01333(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-12-20 Application filed by Merck Serono Sa filed Critical Merck Serono Sa

2005-12-20 Priority claimed from EP05823474A external-priority patent/EP1827461B1/de

2013-12-20 Publication of ME01333B publication Critical patent/ME01333B/me

Links

238000011282 treatment Methods 0.000 title abstract 3
201000006417 multiple sclerosis Diseases 0.000 title abstract 2
PTOAARAWEBMLNO-KVQBGUIXSA-N Cladribine Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PTOAARAWEBMLNO-KVQBGUIXSA-N 0.000 abstract 1
208000007400 Relapsing-Remitting Multiple Sclerosis Diseases 0.000 abstract 1
208000007118 chronic progressive multiple sclerosis Diseases 0.000 abstract 1
229960002436 cladribine Drugs 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
201000008628 secondary progressive multiple sclerosis Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Medicinal Preparation (AREA)
Chemical And Physical Treatments For Wood And The Like (AREA)
Pressure Welding/Diffusion-Bonding (AREA)

MEP-2012-35A 2004-12-22 2005-12-20 Kladribinski režim za liječenje multiple skleroze ME01333B (me)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US63866904P	2004-12-22	2004-12-22
EP04106909		2004-12-22
EP05823474A EP1827461B1 (de)	2004-12-22	2005-12-20	Cladribin dosierschema zur behandlung von multipler sklerose
PCT/EP2005/056954 WO2006067141A1 (en)	2004-12-22	2005-12-20	Cladribine regimen for treating multiple sclerosis

Publications (1)

Publication Number	Publication Date
ME01333B true ME01333B (me)	2013-12-20

Family

ID=34930135

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-2012-35A ME01333B (me)	2004-12-22	2005-12-20	Kladribinski režim za liječenje multiple skleroze

Country Status (11)

Country	Link
AT (1)	ATE547106T1 (de)
CY (1)	CY1125491T1 (de)
DK (1)	DK1827461T3 (de)
ES (4)	ES2666146T3 (de)
HU (1)	HUE035859T2 (de)
LT (1)	LT2805723T (de)
ME (1)	ME01333B (de)
PT (4)	PT1827461E (de)
RS (1)	RS52219B (de)
SI (1)	SI1827461T1 (de)
UA (1)	UA96260C2 (de)

2005
- 2005-12-20 RS RS20120161A patent/RS52219B/sr unknown
- 2005-12-20 AT AT05823474T patent/ATE547106T1/de active
- 2005-12-20 DK DK05823474.1T patent/DK1827461T3/da active
- 2005-12-20 UA UAA200708371A patent/UA96260C2/ru unknown
- 2005-12-20 ES ES14001970.4T patent/ES2666146T3/es not_active Expired - Lifetime
- 2005-12-20 PT PT05823474T patent/PT1827461E/pt unknown
- 2005-12-20 SI SI200531514T patent/SI1827461T1/sl unknown
- 2005-12-20 LT LTEP14001970.4T patent/LT2805723T/lt unknown
- 2005-12-20 ES ES10182676.6T patent/ES2495392T3/es not_active Expired - Lifetime
- 2005-12-20 PT PT181516345T patent/PT3332789T/pt unknown
- 2005-12-20 PT PT221666100T patent/PT4070800T/pt unknown
- 2005-12-20 ES ES05823474T patent/ES2382554T3/es not_active Expired - Lifetime
- 2005-12-20 PT PT140019704T patent/PT2805723T/pt unknown
- 2005-12-20 HU HUE14001970A patent/HUE035859T2/en unknown
- 2005-12-20 ES ES10182632T patent/ES2428741T3/es not_active Expired - Lifetime
- 2005-12-20 ME MEP-2012-35A patent/ME01333B/me unknown
2022
- 2022-06-21 CY CY20221100424T patent/CY1125491T1/el unknown

Also Published As

Publication number	Publication date
ES2666146T3 (es)	2018-05-03
SI1827461T1 (sl)	2012-05-31
RS52219B (sr)	2012-10-31
HUE035859T2 (en)	2018-05-28
LT2805723T (lt)	2018-02-12
DK1827461T3 (da)	2012-03-26
ES2495392T3 (es)	2014-09-17
PT3332789T (pt)	2022-07-05
CY1125491T1 (el)	2025-05-09
ES2428741T3 (es)	2013-11-11
PT2805723T (pt)	2018-01-25
UA96260C2 (ru)	2011-10-25
PT1827461E (pt)	2012-05-07
ES2382554T3 (es)	2012-06-11
PT4070800T (pt)	2024-12-30
ATE547106T1 (de)	2012-03-15

Similar Documents

Publication	Publication Date	Title
GEP20084452B (en)	2008-08-10	Sulfonamide derivatives for the treatment of diseases
TW200635923A (en)	2006-10-16	Tricyclic heterocycles, their manufacture and use as pharmaceutical agents
TW200806300A (en)	2008-02-01	New therapeutic combinations for the treatment of depression
EP4467549A3 (de)	2025-02-19	Zwischenprodukte für n-(3-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)benzamid-derivate
NO20073813L (no)	2007-09-21	Kladribinregime for behandling av multippel sklerose
SG170069A1 (en)	2011-04-29	Quinoline derivatives
PH12013502090A1 (en)	2018-03-21	1,3 oxazines as bace1 and/or bace2 inhibitors
MA34655B1 (fr)	2013-11-02	Dérivés de 2,3- dihydroimidazo[1,2-c]quinazoléine substitués par un aminoalcool utiles pour traiter des troubles hyperprolifératifs et des maladies associées à l'angiogenèse
WO2007022380A3 (en)	2007-06-21	Bis-aryl amide compounds and methods of use
SE0301653D0 (sv)	2003-06-05	Novel compounds
TW200722081A (en)	2007-06-16	New therapeutic combinations for the treatment or prevention of depression
PH12014501334A1 (en)	2014-09-15	Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines
TW200618801A (en)	2006-06-16	Pyrimidine derivatives
TW200734334A (en)	2007-09-16	Treatment of substance abuse
TW200745122A (en)	2007-12-16	New compounds I
SG158863A1 (en)	2010-02-26	Intravenous formulations of pde-5 inhibitors
SE0303480D0 (sv)	2003-12-19	Benzofuranes
TW200531688A (en)	2005-10-01	Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
TW200745085A (en)	2007-12-16	Quinoline derivatives
TW200731975A (en)	2007-09-01	Novel combinations of medicaments for the treatment of respiratory diseases
MY146802A (en)	2012-09-28	Novel drugs for treating respiratory diseases
EA200900552A1 (ru)	2009-10-30	Пирроло[1,2-а]имидазолдион, эффективный при лечении периферической нейротоксичности, индуцированной химиотерапевтическими агентами
ATE496899T1 (de)	2011-02-15	Tetrahydro- und dihydrochinazolinone
TW200745133A (en)	2007-12-16	New compounds II
PT2805723T (pt)	2018-01-25	Regime de cladribina para o tratamento de esclerose múltipla